Understanding the New FDA AI Software Guidelines and Their Impact on Innovation
- Jun 23
- 4 min read
Artificial intelligence (AI) is transforming healthcare, offering new ways to diagnose, treat, and manage diseases. As AI software becomes more integrated into medical devices and healthcare systems, regulatory bodies like the U.S. Food and Drug Administration (FDA) have updated their guidelines to ensure safety and effectiveness. The new FDA AI software guidelines provide a clearer framework for developers and manufacturers, but they also raise questions about how innovation will proceed under these rules.
